These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12775314)

  • 21. Herbal creams used for atopic eczema in Birmingham, UK illegally contain potent corticosteroids.
    Ramsay HM; Goddard W; Gill S; Moss C
    Arch Dis Child; 2003 Dec; 88(12):1056-7. PubMed ID: 14670768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal thinning: evaluation of commercial corticosteroids.
    Wrench R
    Arch Dermatol Res; 1980; 267(1):7-24. PubMed ID: 7387177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.
    Prakash A; Benfield P
    Drugs; 1998 Jan; 55(1):145-63. PubMed ID: 9463794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical hydrocortisone 17-butyrate 21-propionate in the treatment of inflammatory skin diseases: pharmacological data, clinical efficacy, safety and calculation of the therapeutic index.
    Fölster-Holst R; Abeck D; Torrelo A
    Pharmazie; 2016 Mar; 71(3):115-21. PubMed ID: 27183704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of clobetasol propionate emollient 0.05% in the treatment of patients with dry, scaly, corticosteroid-responsive dermatoses.
    Gordon ML
    Clin Ther; 1998; 20(1):26-39. PubMed ID: 9522102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescence spectroscopy: a rapid, noninvasive method for measurement of skin surface thickness of topical agents.
    Rhodes LE; Diffey BL
    Br J Dermatol; 1997 Jan; 136(1):12-7. PubMed ID: 9039288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allergic contact dermatitis due to clobetasone butyrate.
    Murata T; Tanaka M; Dekio I; Tanikawa A; Nishikawa T
    Contact Dermatitis; 2000 May; 42(5):305. PubMed ID: 10789866
    [No Abstract]   [Full Text] [Related]  

  • 28. Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial.
    Lenane P; Macarthur C; Parkin PC; Krafchik B; DeGroot J; Khambalia A; Pope E
    JAMA Dermatol; 2014 Jan; 150(1):47-50. PubMed ID: 24226568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of potential skin atrophy following topical application of weak corticosteroids.
    Black MM; Platt NE; Mugglestone CJ
    Curr Med Res Opin; 1981; 7(7):463-70. PubMed ID: 7261664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of epidermal phospholipase A2 inhibition to monitor topical steroid action.
    Norris JF; Ilderton E; Yardley HJ; Summerly R; Forster S
    Br J Dermatol; 1984 Jul; 111 Suppl 27():195-203. PubMed ID: 6743552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Study of Clobetasone Butyrate Cream (eumovate) and Hydrocortisone Cream in Children with Eczema.
    Haribhakti PB
    Indian J Dermatol Venereol Leprol; 1982; 48(6):344-347. PubMed ID: 28193917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of clobetasone butyrate and other topical steroids on skin thickness of the domestic pig.
    Winter GD; Wilson L
    Br J Dermatol; 1976 May; 94(5):545-50. PubMed ID: 1268065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clobetasone butyrate, a topical steroid in geriatrics].
    Bonavita E; Bassi R; Mengoni M
    Clin Ter; 1985 Mar; 112(5):423-8. PubMed ID: 4017467
    [No Abstract]   [Full Text] [Related]  

  • 34. Hydrocortisone butyrate 0.1% cream (proprietary lipid rich cream vehicle) does not significantly suppress hypothalamic-pituitary-adrenal axis and is effective in pediatric patients 3 months and older with extensive atopic dermatitis.
    Abramovits W; Oquendo M
    Skinmed; 2010; 8(3):150-4. PubMed ID: 21137620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clobetasol propionate emollient 0.05% in the treatment of atopic dermatitis.
    Maloney JM; Morman MR; Stewart DM; Tharp MD; Brown JJ; Rajagopalan R
    Int J Dermatol; 1998 Feb; 37(2):142-4. PubMed ID: 9542676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
    Glade CP; Van Erp PE; Van De Kerkhof PC
    Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinical comparison of topical clobetasone butyrate and sodium cromoglycate in allergic conjunctivitis.
    Frankland AW; Walker SR
    Clin Allergy; 1981 Sep; 11(5):473-8. PubMed ID: 6797754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.
    Lebwohl M; Sherer D; Washenik K; Krueger GG; Menter A; Koo J; Feldman SR
    Int J Dermatol; 2002 May; 41(5):269-74. PubMed ID: 12100701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Systemic effects of topically applied clobetasone 17-butyrate ointment--comparative studies with hydrocortisone 17-butyrate ointment (author's transl)].
    Nihon Hifuka Gakkai Zasshi; 1980; 90(6):491-502. PubMed ID: 6967986
    [No Abstract]   [Full Text] [Related]  

  • 40. Guidelines for using superpotent topical steroids.
    Prawer SE; Katz HI
    Am Fam Physician; 1990 May; 41(5):1531-8. PubMed ID: 2333829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.